ARCUS BIOSCIENCES INC (RCUS) Institutional Ownership and Insiders Activity

ARCUS BIOSCIENCES INC (RCUS) is widely held by institutional investors, with 224 firms reporting positions valued at approximately $3.78B based on SEC Form 13F filings for the quarter ended June 30, 2026.

Gilead Sciences, Inc. is the largest disclosed holder, reporting approximately $968.83M in RCUS holdings in its latest filing.

Recent insider activity includes 8 tracked Form 4 transactions over the last three months, reflecting ongoing executive and director trading activity.